Abstract
Acute onset parkinsonism is rare. The most common explanations are neuroleptic malignant syndrome, viral encephalitis, psychogenic, and catatonia. Testing, including cerebrospinal fluid analyses, toxicology, routine blood evaluations, imaging, and electroencephalograpy, assumes a much greater role than the evaluation of degenerative forms of parkinsonism. Acute parkinsonism should always be considered an emergency. Catatonia and neuroleptic malignant syndrome are treatable disorders that are often readily reversed. Viral encephalitis usually requires aggressive supportive care. Other, less common forms are also discussed in this chapter.
This chapter contains video segments that can be found on the accompanying DVD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Friedman JH. Drug induced parkinsonism. In: Lang AE, Weiner WJ, editors. Drug-induced movement disorders. Mt Kisco: Futura Press; 1992. p. 41–84.
Fahn S, Przedborski S. Parkinsonism. In: Rowland LP, editor. Merritt’s textbook of neurology. 11th ed. Philadelphia: Lippincott Williams and Williams; 2005. p. 828–46.
Caligiuri MP, Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Disord. 2000;47:83–93.
Hymas N, Lees A, Bolton D, et al. The neurology of obsessional slowness. Brain. 1991;114:2203–33.
Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature and pathophysiological hypotheses. Mov Disord. 1994;9:508–20.
Sakurai T, Kimura A, Yamada M, et al. Rapidly progressive parkinsonism that developed one year after ventriculoperitoneal shunting for idiopathic aqueductal stenosis: a case report. Brain Nerve. 2010;62:527–31.
Lees AJ. Secondary Parkinson’s syndrome. In: Jankovic JJ, Tolosa E, editors. Parkinson’s disease and movement disorders. 5th ed. Philadelphia: Lippincott Williams and Williams; 2007. p. 213–24.
Boecker H, Weindl A, Leenders K, et al. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with (18F)FDG and (18F)fluorodopa. Acta Neurol Scand. 1996;93:387–92.
Stern G. The effects of lesions in the substantia nigra. Brain. 1966;89:449–78.
Hunter R, Smith J, Thomson T, Dayan AD. Hemiparkinsonism with infarction of the ilpsilateral substantia nigra. Neuropathol Appl Neurobiol. 1978;4:297–301.
Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke. 2001;32:258–61.
Nagaratnam N, Davies D, Chen E. Clinical effects of anterior cerebral artery infarction. J Stroke Cerebrovasc Dis. 1998;7:391–7.
Dick JP, Benecke R, Rothwell JC, et al. Simple and complex movements in a patient with infarction of the right supplementary motor area. Mov Disord. 1986;1:255–66.
Russmann H, Vingerhoets F, Ghika J, et al. Acute infarction limited to the lenticular nucleus: clinical, etiologic and topographic features. Arch Neurol. 2003;60:351–8.
Turjanski N, Pentland B, Lees AJ, Brooks DJ. Parkinsonism associated with acute intracranial hematomas: an (18F)Dopa positron-emission tomography study. Mov Disord. 1997;12: 1035–8.
Orta Daniel SJ, Ulises RO. Stroke of the substantia nigra and parkinsonism as the first manifestation of systemic lupus erythematosis. Parkinsonism Relat Disord. 2008;14:367–9.
Wang JD, Huang CC, Hwang YH, et al. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989;46:856–9.
Feldman RG. Manganese. In: Occupational and environmental medicine. Philadelphia: Lippincott Raven Press; 1999. p. 168–188.
Sohn YH, Jeong Y, Kim HS, Im JH, Kim JS. The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Arch Neurol. 2000;57:1214–8.
Perry GF. Occupational medicine forum. What are the potential delayed health effects of high level carbon monoxide exposure? J Occup Med. 1994;36:595–7.
Shprecher D, Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation. 2010;26:65–72.
Okuda B, Iwamoto Y, Tachibana H, Sugita M. Parkinsonism after acute cadmium poisoning. Clin Neurol Neurosurg. 1997;99:263–5.
Barbosa ER, Comerlatti LR, Haddad MS, Scaff M. Parkinsonism secondary to ethylene oxide exposure: case report. Arq Neurosiquiatr. 1992;50:531–3.
Laplane D, Attal N, Sauron B, et al. Lesions of the basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry. 1992;44:925–9.
Messing B. Extrapyramidal disturbance after cyanide poisoning. J Neural Transm Suppl. 1991;33:141–7.
Pentore R, Venneri A, Nichelli P. Accidental choke-cherry poisoning: early symptoms and neurological sequelae of an unusual case of cyanide intoxication. Ital J Neurol Sci. 1996;17:233–5.
Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine analogue synthesis. Science. 1983;219:979–80.
Leopold NA, Bara-Jimenez W, Hallett M. Parkinsonism after a wasp sting. Mov Disord. 1999;14:122–7.
Agarwal V, Singh R, Chauhau S, J’Cruz S, Thakur R. Parkinsonism following a honey bee sting. Indian J Med Sci. 2006;60:24–5.
Bogolepov NK, Luzhetskaya TA, Fedin AI, et al. Allergic encephalomyelopolyradiculoneuritis from a wasp sting (clinico-patholo report). Zh Nevropatol Psikhiatr Im SS Korsakova. 1978;78:187–91.
Shandling M, Carlen PL, Lang AE. Parkinsonism in alcohol withdrawal: a follow-up study. Mov Disord. 1990;4:36–9.
Carlen PL, Lee MA, Jacob M, Livishitz O. Parkinsonism provoked by alcoholism. Ann Neurol. 1981;9:84–6.
Lang AE, Marsden CD, Obeso JA, Parkes JD. Alcohol and Parkinson disease. Ann Neurol. 1982;12:254–6.
San Luciano M, Saunders-Pullman R. Substance abuse and movement disorders. Curr Drug Abuse Rev. 2009;2:273–8.
Tinker R, Anderson MG, Anand P, et al. Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatremia. J Neurol Neurosurg Psychiatry. 1990;53:87–9.
Dickoff DJ, Rapps M, Yahr MD. Striatal syndrome following hyponatremia and its rapid correction. Arch Neurol. 1988;45:112–4.
Bernardini GL, Mancall EL. Central pontine myelinolysis. In: Rowland LP, editor. Merritt’s neurology. 11th ed. Philadelphia: Lippincott Williams and Wilins; 2005. p. 965–7.
Hawker K, Lang AE. Hypoxic-ischemic damage of the basal ganglia: case reports and a review of the literature. Mov Disord. 1990;5:219–24.
Straussberg R, Shahar E, Gat R, Brand N. Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery. Dev Med Child Neurol. 1993;35:1007–14.
Li JY, Lai PH, Chen CY, et al. Postanoxic parkinsonism: clinical radiologic and pathologic correlation. Neurology. 2000;55:591–3.
Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions and causality. Mov Disord. 2010;25:1780–90.
Carbone JR. The neuroleptic malignant syndrome and serotonin syndromes. Emerg Clin North Am. 2000;18:317–25.
Susman VL. Clinical management of neuroleptic malignant syndrome. Psychiatr Q. 2001;72:325–6.
Perrin E, Anand E, Dyachkova Y, et al. A prospective observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania. Eur Psychiatry. 2012;27(4):234–9.
Lockman LA, Sung JH, Krivit W. Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrrow transplant recipients. Pediatr Neurol. 1991;7:457–63.
Devinsky O, Lemann W, Evans AC, et al. Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis: a positron emission tomographic and neuropathologic study. Arch Neurol. 1987;44:414–7.
Chuang C, Constantino A, Balmaceda C, et al. Chemotherapy-induced parkinsonism responsive to levodopa: an under-recognized entity? Mov Disord. 2003;18:328–31.
Lima MA, Maradei S, Maranhao Filho P. Cyclosporin-induced parkinsonism. J Neurol. 2009;245:674–5.
Shahar E, Goshen E, Tauber Z, Lahat E. Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol. 1998;18:456–8.
Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood system lupus erythematosis. Arthritis Rheum. 1981;24:1389–95.
Francis A. Catatonia: diagnosis, classification and treatments. Curr Psychiatry Rep. 2010;12:180–5.
Friedman JH. Stereotypy and catatonia. In: Jankovic JJ, Tolosa E, editors. Parkinson’s disease and movement disorders. 5th ed. Baltimore, MD, USA: Williams and Wilkins; 2007. p. 468–80.
Bush G, Fink M, Petrides G, et al. Catatonia: 2. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137–43.
Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile and characteristics. J Neurol Neurosurg Psychiatry. 1994;59:406–12.
Trimble MR. Clinical presentations in neuropsychiatry. Semin Clin Neuropsychiatry. 2002;7:11–7.
Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol. 1995;52:802–10.
Koller WC, Findley LI. Psychogenic tremors. Adv Neurol. 1990;53:271–5.
Von Economo C. Encephalitis lethargica. Wien Klin Wochenschr. 1917;30:581–5.
Urechia CL. Dix cas d’encephalite epidemique avec autopsie. Arch Inter Neurol. 1921;2:65–78.
Cruchet R, Moutier F, Calmette A. Quarante cas d’encephalo-myelite subaigue. Bull Mem Soc Med d’Hop. 1917;41:614–6.
Etienne G. Myelities aigues epidemiques. Deux épidémies militares. Rev Neurol. 1917;24:375–6.
Watson AJ. Origin of encephalitis lethargica. Chin Med J. 1928;42:427–32.
Von Economo C. Encephalitis lethargica: its sequelae and treatment (translated by K.O. Newman). London: Oxford University Press; 1931. p. I–XIV. 1–200.
Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol. 1965;12:227–39.
Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. Brain. 1993;116:281–2.
Wilson SAK. Epidemic encephalitis. In: Neurology. Volume 1. Baltimore: Williams and Wilkins C; 1940. p. 118–65.
Morrison PJ, Patterson VH. Cranial dystonia (Meige syndrome) in postencephalitic parkinsonism. Mov Disord. 1992;7:90–1.
Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm. 1997;104:845–65.
Litvan I, Jankovic J, Goetz CG. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol. 1998;5:451–7.
Vilensky JA, Gilman S, McCall S. A historical analysis of the relationship between encephalitis lethargica and post-encephalitic parkinsonism: a complex rather than a direct relationship. Mov Disord. 2010;25:116–23.
Duncan AG. The sequelae of encephalitis lethargica. Brain. 1924;47:76–108.
Calne DB, Lees AJ. Late progression of post-encephalitic Parkinson syndrome. Can J Neurol Sci. 1988;15:135–8.
Vieregge P, Reinhardt V, Hoft B. Is progression in postencephalitic Parkinson’s disease late and age-related? J Neurol. 1991;238:299–303.
Ravenholt RT, Foege WH. 1918 Influenza, encephalitis lethargica, parkinsonism. Lancet. 1982;2:860–2.
Laidlaw PP. Epidemic influenza: a virus disease. Lancet. 1935;1:1118–24.
Casals J, Elizan TS, Yahr MD. Postencephalitic parkinsonism—a review. J Neural Transm. 1998;105:645–76.
Gamboa ET, Wolf A, Yahr MD, et al. Influenza virus antigen in postencephalitic parkinsonism brain. Arch Neurol. 1974;31:228–32.
Martilla RJ, Halomen P, Rinne UK. Influenza virus antibodies in parkinsonism. Comparison of postencephalitic and idiopathic Parkinson patients and matched controls. Arch Neurol. 1977;34:99–100.
Elizan T, Schwartz J, Yahr MD, Casals J. Antibodies against arboviruses in postencephalitic and idiopathic Parkinson’s disease. Arch Neurol. 1978;35:257–60.
Takahashi M, Yamada T, Nakajima S, et al. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med. 1995;181:2161–9.
Elizan TS, Casals J, Yahr MD. Antineurofilament antibodies in postencephalitic and idiopathic Parkinson’s disease. J Neurol Sci. 1983;59:341–7.
Elizan TS, Yahr MD. Histocompatibility antigens and postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1983;46:688–93.
Lees AJ, Stern GM, Compston DAS. Histocompatibility antigens and post-encephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1982;45:1060–1.
Williams A, Houff S, Lees A, Calne DB. Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry. 1979;42:790–2.
Rail D, Scholtz C, Swash M. Postencephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry. 1981;44:670–6.
Clough CG, Plaitakis A, Yahr MD. Oculogyric crises and parkinsonism: a case of recent onset. Arch Neurol. 1983;40:36–7.
Johnson J, Lucey PA. Encephalitis lethargica, a contemporary cause of catatonic stupor: a report of two cases. Br J Psychiatry. 1987;151:550–2.
Howard RS, Lees AJ. Encephalitis lethargica. A report of four recent cases. Brain. 1987;110:19–33.
Misra UK, Kalita J. Spectrum of movement disorders in encephalitis. J Neurol. 2010;257: 2052–8.
Ghaemi M, Rudolf S, Schmulling S, Bamborschke S, Heiss WD. FDG- and Dopa-PET in postencephalitic parkinsonism. J Neural Transm. 2000;107:1289–95.
Cree BC, Bernardini GL, Hays AP, Lowe G. A fatal case of coxackievirus B4 meningoencephalitis. Arch Neurol. 2003;60:107–8.
Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology. 1987;37:37–41.
Carranzana EJ, Rossitch E, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry. 1989;12:1445–7.
Navia BA, Petito CK, Gold JWM, et al. Cerebral toxoplasmosis complicating the acquired immunodeficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986;19:224–38.
Noel S, Gaillaume MP, Telerman-Toppet N, et al. Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS). Acta Neurol Belg. 1992;92:148–56.
Maggi P, de Mari M, Moramarco A, Fiorentino P, Lamberti P, Angarano G. Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions. Neurol Sci. 2002;21:173–6.
De Mattos JP, Rosso AL, Correa RD, et al. Involuntary movements and AIDS: report of seven cases and review of the literature. Arq Neuropsiquiatr. 1993;51:491–7.
Misattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684–9.
Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs. 2002;16:663–8.
Sandyk R. Parkinsonism secondary to neurosyphilis: a case report. S Afr Med J. 1983;23:665–6.
Garcia-Moreno JM, Izquierdo G, Chacon J, Angulo S, Borobio MV. Neuroborreliosis in a patient with progressive supranuclear paralysis: an association or a cause? Rev Neurol. 1997;25:1919–21.
Zambrino CA, Zorzi G, Lanzi G, Uggetti C, Egitto MC. Bilateral striatal necrosis associated with mycoplasma pnuemoniae infection in an adolescent: clinical and neurodiagnostic follow-up. Mov Disord. 2000;15:1023–6.
Al-Mateen M, Gibbs M, Dietrch R, Mitchell WG, Menkes JH. Encephalitis lethargica-like illness in a girl with mycoplasma infection. Neurology. 1988;38:1155–8.
Saitoh S, Wada T, Narita M, et al. Mycoplasma pneumoniae infection may cause striatal lesions leading to acute neurological dysfunction. Neurology. 1993;43:2150–1.
Kim JS, Choi IS, Lee MC. Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection. Mov Disord. 1995;10:510–2.
Brandel J, Noseda G, Agid Y. Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord. 1996;11:333–5.
Singer C, Berger JR, Bowen BC, Bruce JH, Weiner WJ. Akinetic-rigid syndrome in a 13-year old girl with HIV-related progressive multifocal leukoencephalopathy. Mov Disord. 1993;8:113–6.
Werring DJ, Chaudhuri KR. HIV-related progressive multifocal leukoencephalopathy presenting with an akinetic-rigid syndrome. Mov Disord. 1996;11:758–61.
De la Fuente J, Bordon J, Moreno JA, et al. Parkinsonism in an HIV-infected patient with hypodense cerebral lesion. Tuber Lung Dis. 1996;77:191–2.
Strong G. Parkinson’s syndrome following herpes ophthalmicus. Br Med J. 1952;1:533.
Fenichel GM. Postvaccinal parkinsonism. Mov Disord. 1993;8:253.
Reijneveld JC, Taphoorn MJB, Hoogenraad TU, Van Gijn J. Severe but transient parkinsonism after tetanus vaccination. J Neurol Neurosurg Psychiatry. 1997;63:258–9.
McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic parkinson cases. J Neuropathol Exp Neurol. 2001;60:696–704.
Krusz JC, Koller WC, Ziegler DK. Historical review: abnormal movements associated with epidemic encephalitis lethargica. Mov Disord. 1987;2:137–41.
Elizan TS, Casals J. Astrogliosis in von Economo’s and postencephalitic Parkinson’s diseases supports probable viral etiology. J Neurol Sci. 1991;105:131–4.
Hof PR, Charpiot A, Delacourte A, et al. Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett. 1992;139:10–4.
Josephs KA, Parisi JE, Dickson DW. Alpha-synuclein studies are negative in postencephalitic parkinsonism of von Economo. Neurology. 2002;59:645–6.
Ikeda K, Akiyama H, Kondo H, Ikeda K. Anti-tau-positive glial fibrillary tangles in the brain of post-encephalitic parkinsonism of Economo type. Neurosci Lett. 1993;162(1–2):176–8.
Wong KT, Allen IV, McQuaid S, McConnell R. An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic parkinsonism. Clin Neuropathol. 1996;15:22–5.
Shen WC, Ho YJ, Lee SK, Lee KR. MRI of transient post-encephalitic parkinsonism. J Comput Assist Tomogr. 1994;18:155–9.
Caparros-Lefebvre D, Cabaret M, Godefroy O, et al. PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism. J Neural Transm. 1998;105:489–95.
Solbrig MV, Nashef L. Acute parkinsonism in suspected herpes simplex encephalitis. Mov Disord. 1993;8:233–4.
Savant CS, Singhal BS, Jankovic J, Khan MAK, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord. 2003;18:213–27.
Alves RSC, Barbosa ER, Scaff M. Postvaccinal parkinsonism. Mov Disord. 1992;7:178–80.
Calne DB, Stern GM, Laurence DR. L-dopa in postencephalitic parkinsonism. Lancet. 1969;1:744–6.
Sacks O. Awakenings. New York: Harper Perennial; 1990.
Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with post-encephalitic parkinsonism to levodopa. J Neurol Neurosurg Psychiatry. 1972;35:487–95.
Walters JH. Postencephalitic parkinson syndrome after meningoencephalitis due to coxackie virus group B, type 2. N Engl J Med. 1960;263:744–7.
Posner CM, Huntley CJ, Poland JD. Para-encephalitic parkinsonism. Acta Neurol Scand. 1969;45:199–215.
Giraldi C, Mazzoni M, Morgantini PG, Lunardi CV. Parkinsonian syndrome during viral encephalitis. Riv Neurol. 1991;61:183–5.
Ickenstein GW, Klotz JM, Langorh HD. Virus encephalitis with symptomatic parkinsonian syndrome, diabetes insipidus and panhypopituitarism. Fortschr Neurol Psychiatr. 1999;67: 476–81.
Hsieh JC, Lue KH, Lee YL. Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis. Arch Dis Child. 2002;87:358–9.
Isgreen WP, Chutarian AM, Fahn S. Sequential parkinsonism and chorea following “mild” influenza. Trans Am Neurol Assoc. 1976;101:56–9.
Shiraki H, Goto A, Narabayashi H. Etat passe et present de l’encephalite Japonnaise au Japon. Rev Neurol (Paris). 1963;108:633–96.
Ishii T, Marsushita M, Hamada S. Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol (Berl). 1977;38:181–6.
Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J Neurol. 1993;240:59–60.
Pradham S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of the substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781–6.
Scheid W, Ackerman R, Felgenhauer K. Lymphozytare choriomeningitis unter dem bild der Encephalitis lethargica. Dtsch Med Wochenschr. 1968;93:940–3.
Adair CV, Gould RL, Smadel JE. Aseptic meningitis, a disease of diverse etiology: clinical and etiological studies of 854 cases. Ann Intern Med. 1953;39:675–704.
Bennett NMcK. Murray Valley encephalitis, 1947: clinical features. Med J Aust. 1976;2:446–50.
Bickerstaff ER, Cloake PCP. Mesencephalitis and rhombencephalitis. Br Med J. 1951;2:77–81.
Thieffrey S. Enterovirus et maladies du systeme nerveux: revisiou critique et experience personnelle. Rev Neurol (Paris). 1963;108:753–76.
Barrett AM, Gairdner D, McFarlan AM. An outbreak of encephalitis possibly due to poliomyitis virus. Br Med J. 1952;1:1317–22.
Vincent FM, Myers WG. Poliomyelitis and parkinsonism. N Engl J Med. 1978;298:688–9.
Mellon AF, Appleton RE, Gardner-Medwin D, Aynsley-Green A. Encephalitis lethargica-like illness in a 5 year old. Dev Med Child Neurol. 1991;33:153–6.
Meyer B. Encephalitis after measles with severe parkinsonian rigidity: recovery. Br Med J. 1943;1:508.
Henner K, Hanzal F. Encephalite tchecoslavaque a tiques. Rev Neurol (Paris). 1957;96:384–408.
Henner K, Hanzal F. Les encephalities europeenes a tiques. Rev Neurol (Paris). 1963;108:697–752.
Radsel-Melvescek A, Marolt-Gomiscek M, Pouse-Trojar M, Gajsek-Zima M. Late sequelae after tick-borne meningoencephalitis in patients treated at the hospital for infectious diseases at University Medical Centre of Ljubljana during the period 1974–1975. Zentralbl Bakteriol. 1980;9(suppl):281–4.
Cerna F, Mehrad B, JP Luby, et al. St. Louis encephalitis and the substantia nigra: MR imaging evaluation. Am J Neuroradiol. 1999;20:1281–3.
Wasay M, Diaz-Arastia R, Suss R, et al. St. Louis encephalitis: a review of 11 cases in a 1995 Dallas, Texas epidemic. Arch Neurol. 2000;57:114–8.
Finley KH. Postencephalitic manifestations of viral encephalitides. In: Fields WS, Blattner RJ, editors. Viral encephalitis. Springfield Ill: CC Thomas; 1958. p. 69–94.
Finley KH, Riggs N. Convalescence and sequelae. In: Monath TP, editor. St. Louis encephalitis. Washington DC: Am Pub Hlth Assoc; 1980. p. 535–50.
Fulton JC, Burton AN. After effects of WEE infection in man. Canad MAJ. 1953;69: 268–72.
Mulder DW, Parrot M, Thaler M. Sequelae of western equine encephalitis. Neurology. 1951;1:318–27.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Movement_Disorders_Emergencies_C2.mov (54,258) KB
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fernandez, H.H., Friedman, J.H. (2013). Acute Parkinsonism. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-60761-835-5_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-834-8
Online ISBN: 978-1-60761-835-5
eBook Packages: MedicineMedicine (R0)